Viewing nowBoryeong Glimepiride Tablets 2 mg
Glimepiride 2mg
Tablet · Prescription medication
Boryeong Co., Ltd.

MFDS item code 200300923 · Notified 2003.10.27 · Insurance code 641900930
Improvement of glycemic control in type 2 diabetes mellitus
This drug is used to enhance blood sugar control in patients with type 2 diabetes, in conjunction with dietary therapy and exercise therapy. It can be administered alone, and in cases where blood sugar control is difficult with oral hypoglycemic agents, it may be used in combination with insulin. It may also be used together with metformin in cases where blood sugar control is inadequate with either sulfonylurea or metformin monotherapy. This effectively improves blood sugar control, aiding in diabetes management.
Adjust individually for each patient. Swallow without chewing with at least 1/2 glass of water. This drug is administered orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If needed, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional effect with doses above 4 mg, but some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider concomitant use with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the amount of this drug needed may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no precise dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is recommended to follow the method described under Initial Dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the efficacy and duration of action of the previous medication. 4) Dose adjustment While taking this drug, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate ingestion of sugar. Hypoglycemia may recur after initially successful management during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this drug with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) is greater than 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose must be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. With combination therapy of this drug and metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this drug and metformin, and the risk may increase. Appropriate precautions should be taken.
This drug should not be administered to patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a coma. Patients who have had allergic reactions to this drug or to sulfonylureas should also not use it. It is advisable not to use this drug in patients with severely impaired liver or kidney function, and switching to insulin therapy is recommended in such cases. Women who are pregnant, may become pregnant, or are breastfeeding should not take this drug. Insulin therapy is more appropriate in patients with severe infections or before and after surgery or in cases of severe trauma. Patients with gastrointestinal disorders may experience hypoglycemia due to poor absorption of food; therefore, caution is advisable. Close monitoring is necessary, especially at the beginning of treatment, as the risk of hypoglycemia is particularly high in elderly patients, poorly nourished patients, or patients with irregular eating patterns. Patients frequently consuming alcohol or with reduced kidney and liver function are also at increased risk of hypoglycemia. Caution is needed for patients who overdose on this drug or have endocrine disorders, as well as those taking other medications. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, confusion, drowsiness, and loss of consciousness; upon experiencing symptoms, immediate intake of sugar is essential. Rare adverse effects may include visual disturbances, gastrointestinal symptoms, liver dysfunction, blood disorders, and allergic reactions; if any unusual symptoms occur, immediate consultation with a doctor is required. To control blood sugar levels, it is important to practice dietary management and exercise therapy in addition to taking this drug. When experiencing hypoglycemia, patients should always carry sugar-sweetened beverages or sugar, as artificial sweeteners are ineffective. Particularly in stressful situations, surgeries, or infections, blood sugar control may become challenging, and switching to insulin therapy may be necessary. The dosage for elderly patients with decreased renal function should be adjusted accordingly. In cases of overdose, appropriate emergency measures such as inducing vomiting, preventing drug absorption, or administering glucose injection are required, and long-term monitoring is essential since there is a potential for recurrent hypoglycemia. Keep this medication out of reach of children and store it in its original container to prevent misuse or quality degradation. This drug is not recommended for pregnant or breastfeeding women; if necessary, switching to insulin therapy is advisable.
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it should be stored in a sealed container. The appropriate storage temperature is room temperature between 1 to 30 degrees Celsius, and it is advisable to avoid excessive heat or cold.
Green, rectangular tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Boryeong Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.